|
1
|
Chen L, Qu J, Cheng T, Chen X and Xiang C:
Menstrual blood-derived stem cells: Toward therapeutic mechanisms,
novel strategies, and future perspectives in the treatment of
diseases. Stem Cell Res Ther. 10(406)2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Chen L, Qu J and Xiang C: The
multi-functional roles of menstrual blood-derived stem cells in
regenerative medicine. Stem Cell Res Ther. 10(1)2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Zhou J, Tan X, Tan Y, Li Q, Ma J and Wang
G: Mesenchymal stem cell derived exosomes in cancer progression,
metastasis and drug delivery: A comprehensive review. J Cancer.
9:3129–3137. 2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Raik S, Kumar A and Bhattacharyya S:
Insights into cell-free therapeutic approach: Role of stem cell
‘soup-ernatant’. Biotechnol Appl Biochem. 65:104–118.
2018.PubMed/NCBI View
Article : Google Scholar
|
|
5
|
Foo JB, Looi QH, Chong PP, Hassan NH, Yeo
GEC, Ng CY, Koh B, How CW, Lee SH and Law JX: Comparing the
therapeutic potential of stem cells and their secretory products in
regenerative medicine. Stem Cells Int. 2021(2616807)2021.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Huang-Doran I, Zhang CY and Vidal-Puig A:
Extracellular vesicles: Novel mediators of cell communication in
metabolic disease. Trends Endocrinol Metab. 28:3–18.
2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Xu HK, Chen LJ, Zhou SN, Li YF and Xiang
C: Multifunctional role of microRNAs in mesenchymal stem
cell-derived exosomes in treatment of diseases. World J Stem Cells.
12:1276–1294. 2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Parfejevs V, Sagini K, Buss A, Sobolevska
K, Llorente A, Riekstina U and Abols A: Adult stem cell-derived
extracellular vesicles in cancer treatment: Opportunities and
challenges. Cells. 9(1171)2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Liu K, Zhou Z, Pan M and Zhang L: Stem
cell-derived mitochondria transplantation: A promising therapy for
mitochondrial encephalomyopathy. CNS Neurosci Ther. 27:733–742.
2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Nakamura Y, Park JH and Hayakawa K:
Therapeutic use of extracellular mitochondria in CNS injury and
disease. Exp Neurol. 324(113114)2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Warburg O, Wind F and Negelein E: The
metabolism of tumors in the body. J Gen Physiol. 8:519–530.
1927.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Viale A, Corti D and Draetta GF: Tumors
and mitochondrial respiration: A neglected connection. Cancer Res.
75:3685–3686. 2015.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Jia D, Lu M, Jung KH, Park JH, Yu L,
Onuchic JN, Kaipparettu BA and Levine H: Elucidating cancer
metabolic plasticity by coupling gene regulation with metabolic
pathways. Proc Natl Acad Sci U S A. 116:3909–3918. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Permuth-Wey J, Chen YA, Tsai YY, Chen Z,
Qu X, Lancaster JM, Stockwell H, Dagne G, Iversen E, Risch H, et
al: Inherited variants in mitochondrial biogenesis genes may
influence epithelial ovarian cancer risk. Cancer Epidemiol
Biomarkers Prev. 20:1131–1145. 2011.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Caicedo A, Fritz V, Brondello JM, Ayala M,
Dennemont I, Abdellaoui N, de Fraipont F, Moisan A, Prouteau CA,
Boukhaddaoui H, et al: MitoCeption as a new tool to assess the
effects of mesenchymal stem/stromal cell mitochondria on cancer
cell metabolism and function. Sci Rep. 5(9073)2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Mombo NB, Gerbal-Chaloin S, Bokus A,
Daujat-Chavanieu M, Jorgensen C, Hugnot JP and Vignais ML:
MitoCeption: Transferring isolated human msc mitochondria to
glioblastoma stem cells. J Vis Exp. 22(55245)2017.PubMed/NCBI View
Article : Google Scholar
|
|
17
|
Gomzikova MO, James V and Rizvanov AA:
Mitochondria donation by mesenchymal stem cells: Current
understanding and mitochondria transplantation strategies. Front
Cell Dev Biol. 9(653322)2021.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Signorile A, De Rasmo D, Cormio A, Musicco
C, Rossi R, Fortarezza F, Palese LL, Loizzi V, Resta L, Scillitani
G, et al: Human ovarian cancer tissue exhibits increase of
mitochondrial biogenesis and cristae remodeling. Cancers (Basel).
11(1350)2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Ke X, Li L, Li J, Zheng M and Liu P:
Anti-oncogenic PTEN induces ovarian cancer cell senescence by
targeting P21. Cell Biol Int. 46:118–128. 2022.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Li F, Wang Y, Li Y, Yang H and Wang H:
Quantitative analysis of the global proteome in peripheral blood
mononuclear cells from patients with new-onset psoriasis.
Proteomics. 18(e1800003)2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Lin H, Zhang W, Xu Y, You Z, Zheng M, Liu
Z and Li C: 4D label-free quantitative proteomics analysis to
screen potential drug targets of Jiangu Granules treatment for
postmenopausal osteoporotic rats. Front Pharmacol.
13(1052922)2022.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Heil LR, Remes PM and MacCoss MJ:
Comparison of unit resolution versus high-resolution accurate mass
for parallel reaction monitoring. J Proteome Res. 20:4435–4442.
2021.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Dacks JB, Field MC, Buick R, Eme L,
Gribaldo S, Roger AJ, Brochier-Armanet C and Devos DP: The changing
view of eukaryogenesis-fossils, cells, lineages and how they all
come together. J Cell Sci. 129:3695–3703. 2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Pavlova NN and Thompson CB: The emerging
hallmarks of cancer metabolism. Cell Metab. 23:27–47.
2016.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Vaupel P, Schmidberger H and Mayer A: The
Warburg effect: Essential part of metabolic reprogramming and
central contributor to cancer progression. Int J Radiat Biol.
95:912–919. 2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Payen VL, Zampieri LX, Porporato PE and
Sonveaux P: Pro- and antitumor effects of mitochondrial reactive
oxygen species. Cancer Metastasis Rev. 38:189–203. 2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Zampieri LX, Grasso D, Bouzin C, Brusa D,
Rossignol R and Sonveaux P: Mitochondria participate in
chemoresistance to cisplatin in human ovarian cancer cells. Mol
Cancer Res. 18:1379–1391. 2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Emmings E, Mullany S, Chang Z, Landen CN
Jr, Linder S and Bazzaro M: Targeting mitochondria for treatment of
chemoresistant ovarian cancer. Int J Mol Sci.
20(229)2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Matassa DS, Amoroso MR, Lu H, Avolio R,
Arzeni D, Procaccini C, Faicchia D, Maddalena F, Simeon V,
Agliarulo I, et al: Oxidative metabolism drives
inflammation-induced platinum resistance in human ovarian cancer.
Cell Death Differ. 23:1542–1554. 2016.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Ghareeb H and Metanis N: The thioredoxin
system: A promising target for cancer drug development. Chemistry.
26:10175–10184. 2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Karlenius TC and Tonissen KF: Thioredoxin
and cancer: A role for thioredoxin in all states of tumor
oxygenation. Cancers (Basel). 2:209–232. 2010.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Pustylnikov S, Costabile F, Beghi S and
Facciabene A: Targeting mitochondria in cancer: Current concepts
and immunotherapy approaches. Transl Res. 202:35–51.
2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Wang J, Li H, Yao Y, Zhao T, Chen YY, Shen
YL, Wang LL and Zhu Y: Stem cell-derived mitochondria
transplantation: A novel strategy and the challenges for the
treatment of tissue injury. Stem Cell Res Ther.
9(106)2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Kheirandish-Rostami M, Roudkenar MH,
Jahanian-Najafabadi A, Tomita K, Kuwahara Y, Sato T and Roushandeh
AM: Mitochondrial characteristics contribute to proliferation and
migration potency of MDA-MB-231 cancer cells and their response to
cisplatin treatment. Life Sci. 244(117339)2020.PubMed/NCBI View Article : Google Scholar
|
